Grafa News and Videos — Page 318

Oil prices declined and U.S. stocks gained on Monday after a pause in fighting between the United States and Iran increased expectations that diplomatic efforts could continue.

MapLight Therapeutics NASDAQ:MPLT) reported positive topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA in adults with acute exacerbation of schizophrenia.

Neumora Therapeutics (NASDAQ:NMRA) reported favorable results from a repeat 162-animal toxicology study for its NMRA-215 obesity program.

VERAXA Biotech (NASDAQ:VRXA) announced that its VXA-222 bispecific antibody-drug conjugate programme has reached a technical milestone and advanced into the next phase of its collaboration with OmniAb (NASDAQ:OABI).

Yarrow Bioscience (NASDAQ:YARW) completed its merger with VYNE Therapeutics and closed previously announced private financings totaling approximately $200 million to support its biotechnology development programme.

Lakeland Financial Corporation (NASDAQ:LKFN) reported record second-quarter 2026 net income of $28.4 million, or $1.13 per diluted share, compared with $27 million, or $1.04 per share, in the second quarter of 2025.

Nuwellis (NASDAQ:NUWE), a medical technology company focused on cardiorenal solutions, reported preliminary second-quarter 2026 revenue growth of 14% year over year and first-half 2026 revenue growth of 20%.

Diana (NYSE:DSX) terminated its tender offer for Genco (NYSE:GNK) to force negotiations regarding its $27.34 per share acquisition proposal.

Sierra Bancorp (NASDAQ:BSRR), parent company of Bank of the Sierra, reported second-quarter 2026 net income of $9.9 million, or $0.77 per diluted share, compared with $10.6 million, or $0.78 per share, in the second quarter of 2025.

Citizens Community Bancorp (NASDAQ:CZWI) reported second-quarter 2026 net income of $1.1 million following higher credit loss provisions.